Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;29(6):237–242. doi: 10.1002/clc.4960290603

Implantable cardiac arrhythmia devices—Part II: Implantable cardioverter defibrillators and implantable loop recorders

Fred Kusumoto 1,✉, Nora Goldschlager 2
PMCID: PMC6654606  PMID: 16796072

Abstract

Implantable cardiac devices have become firmly entrenched as important therapeutic tools for a variety of cardiac conditions. The second part of this two‐part review discusses the contemporary use and follow‐up of implantable cardioverter defibrillators (ICD) and the implantable loop recorder. The ICD has become the standard therapy for protecting patients against sudden cardiac death. Two recent trials, the Multicenter Automatic Defibrillator Trial II (MADIT II) and the Sudden Cardiac Death Heart Failure Trial (SCD‐HEFT), demonstrated that the ICD is associated with a significant survival benefit for patients with reduced ejection fraction (<0.30–0.35), particularly if heart failure symptoms are present. The ICD has an important role in the management of other conditions associated with a high risk for sudden death, such as hypertrophic cardiomyopathy, long QT syndrome, and Brugada syndrome. The implantable loop recorder has become an important diagnostic tool for the patient with unexplained syncope.

Keywords: pacemakers, defibrillators, cardiac resynchronization, loop recorder, syncope, implantable devices

Full Text

The Full Text of this article is available as a PDF (43.9 KB).

References

  • 1. AVID Investigators : A comparison of antiarrhythmic‐drug therapy with implantable defibrillators in patients resuscitated from near‐fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576–1583 [DOI] [PubMed] [Google Scholar]
  • 2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B: Canadian Implantable Defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator. Circulation 2000; 101: 1297–1301 [DOI] [PubMed] [Google Scholar]
  • 3. Wyse GD, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MA, Wilkoff BL, Greene HL, for the AVID Investigators : Life‐threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow‐up. J Am Coll Cardiol 2001; 38: 1718–1724 [DOI] [PubMed] [Google Scholar]
  • 4. Ehlert FA, Cannom DS, Renfroe EG: Comparison of dilated cardiomyopathy and coronary artery disease in patients with life‐threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry. Am Heart J 2001; 142: 816–822 [DOI] [PubMed] [Google Scholar]
  • 5. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators : Electrophysiology testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000; 342: 1937–1945 [DOI] [PubMed] [Google Scholar]
  • 6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933–1940 [DOI] [PubMed] [Google Scholar]
  • 7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators : A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 182–190 [DOI] [PubMed] [Google Scholar]
  • 8. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daibert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–893 [DOI] [PubMed] [Google Scholar]
  • 9. Bardy G, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp‐Channing N, Davidson‐Ray LD, Faulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) Investigators : Amiodarone or an implantable cardioverter‐defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–237 [DOI] [PubMed] [Google Scholar]
  • 10. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, for the DINAMIT Investigators : Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481–2488 [DOI] [PubMed] [Google Scholar]
  • 11. Malm S, Frigstad S, Sagberg E, Larssson H, Skjaerpe T: Accuracy and reproducibile measurement of left ventricular volume and ejection fraction by contrast echocardiography: A comparison with magnetic resonance imaging. J Am Coll Cardiol 2004; 44: 1030–1035 [DOI] [PubMed] [Google Scholar]
  • 12. Wilber D, Zareba W, Hall W, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ: Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004; 109: 1082–1084 [DOI] [PubMed] [Google Scholar]
  • 13. Solomon SD, Zelenkofske S, McMurray JVJ, Finn PV, Velazquez E, Ertl G, Haranyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, for the Valsartant in Acute Myocardial Infarction Trial (VALIANT) Investigators: Sudden death in patients with myocardial infarcion and left ventricular dysfunction, heart failure, or both . N Engl J Med 352: 2581–2588 [DOI] [PubMed] [Google Scholar]
  • 14. Sanders GD, Hlatky MA, Every NR: Potential cost‐effectiveness of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med 2001; 135: 870–883 [DOI] [PubMed] [Google Scholar]
  • 15. Hlatky MA: Evidence‐based use of cardiac procedures and devices. N Engl J Med 2004; 350: 2126–2128 [DOI] [PubMed] [Google Scholar]
  • 16. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, for the AMIOVIRT Investigators : Amiodarone versus implantable cardioverter‐defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia‐AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707–1712 [DOI] [PubMed] [Google Scholar]
  • 17. Bansch D, Antz M, Boczor S, Volkmer Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453–1458 [DOI] [PubMed] [Google Scholar]
  • 18. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, for the Defibrillators in Non‐Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators : Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151–2158 [DOI] [PubMed] [Google Scholar]
  • 19. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT: Hypertrophic cardiomyopathy in a large community‐based population. Clinical outcome and identification of risk factors for sudden cardiac death and deterioration. J Am Coll Cardiol 2003; 41: 987–993 [DOI] [PubMed] [Google Scholar]
  • 20. Maron BJ, Shen W‐K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P: Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365–373 [DOI] [PubMed] [Google Scholar]
  • 21. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M: Implantable cardioverter defibrillator in high‐risk long QT patients. J Cardiovasc Electrophysiol 2003; 14: 337–341 [DOI] [PubMed] [Google Scholar]
  • 22. Brugada P, Brugada R, Brugada J: The Brugada syndrome. Curr Cardiol Rev 2000; 2: 507–514 [DOI] [PubMed] [Google Scholar]
  • 23. Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, Sitthisook S, Chaothawee L, Lai MY, Anzen SP: Defibrillator vs. Beta Blockers for unexpected death in Thailand (DEBUT): A randomized clinical trial. Circulation 2003; 107: 221–226 [DOI] [PubMed] [Google Scholar]
  • 24. Silka MJ, Hardy BG, Menashe VD, Morris CD: A population‐based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32: 245–251 [DOI] [PubMed] [Google Scholar]
  • 25. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J: Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002; 40: 1675–1680 [DOI] [PubMed] [Google Scholar]
  • 26. Glikson M, Luria D, Friedman PA, Trusty JM, Benderly M, Hammill SC, Stanton MS: Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol 2000; 11: 127–135 [DOI] [PubMed] [Google Scholar]
  • 27. US Food and Drug Administration Website : Medtronic issues notification regarding certain implantable defibrillator models. Available at http://www.fda.gov/oc/po/firmrecalls/medtronic20_05.html. Accessed September 16, 2005.
  • 28. US Food and Drug Administration Website : FDA statement on Guidant Corporations worldwide physician communications. Available at http://www.fda.gov/opacom/Enforce.html. Accessed September 16, 2005.
  • 29. Maisel WH: Safety issues involving medical devices. J Am Med Assoc 2005; 294: 955–958 [DOI] [PubMed] [Google Scholar]
  • 30. Krahn AD, Klein GJ, Yee R, Skanes AC: Randomized Assessment of Syncope Trial. Circulation 2001: 46–51 [DOI] [PubMed]
  • 31. Moya A, Brignole M, Menozzi C, Garcia‐Civera R, Tognarini S, Mont L, Botto G, Giada F, Cornacchia D, for the International Study on Syncope of Uncertain Etiology (ISSUE) Investigators : Mechanism of syncope in patients with isolated syncope and in patients with tilt‐positive syncope. Circulation 2001; 104: 1261–1267 [DOI] [PubMed] [Google Scholar]
  • 32. Menozzi C, Brignole M, Garcia‐Civera R, Moya A, Botto G, Tercedor L, Migliorini R, Navarro X, for the International Study on Syncope of Uncertain Etiology (ISSUE) Investigators : Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 2002; 105: 2741–2745 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES